Camber Capital Management LP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 128 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Camber Capital Management LP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2020$36,288,000
+77.9%
2,800,000
+100.0%
0.96%
-18.0%
Q2 2020$20,398,000
+62.1%
1,400,000
-5.3%
1.17%
+55.4%
Q1 2020$12,584,000
-74.1%
1,478,753
-49.9%
0.75%
-69.6%
Q4 2019$48,587,000
+16.6%
2,950,0000.0%2.47%
+12.9%
Q3 2019$41,654,000
+3.6%
2,950,000
+47.5%
2.19%
+16.8%
Q2 2019$40,220,000
-49.4%
2,000,0000.0%1.88%
-52.7%
Q1 2019$79,500,000
+20.4%
2,000,000
+5.3%
3.96%
+26.5%
Q4 2018$66,006,000
-1.5%
1,900,000
+17.3%
3.13%
+9.2%
Q3 2018$66,987,000
+12.5%
1,620,0000.0%2.87%
+25.1%
Q2 2018$59,535,000
-5.6%
1,620,000
+0.2%
2.29%
-26.0%
Q1 2018$63,051,000
+550.5%
1,616,690
+201.9%
3.10%
+553.2%
Q4 2017$9,693,000
+9.4%
535,5000.0%0.47%
-15.7%
Q3 2017$8,863,000
+18.2%
535,5000.0%0.56%
+54.0%
Q2 2017$7,497,000
+191.8%
535,500
+328.4%
0.36%
+251.0%
Q1 2017$2,569,000125,0000.10%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
KPCB XV Associates, LLC 1,876,650$29,182,00013.03%
Copernicus Capital Management, LLC 50,000$778,00012.27%
Antipodean Advisors LLC 1,000,000$15,550,0004.28%
BRIDGER MANAGEMENT, LLC 1,325,188$20,607,0001.92%
Redmile Group, LLC 6,449,577$100,291,0001.48%
MAVERICK CAPITAL LTD 7,704,676$119,808,0001.12%
Baupost Group 8,477,488$131,825,0001.07%
ACT CAPITAL MANAGEMENT, LLC 116,900$1,818,0000.93%
Trellus Management Company, LLC 73,056$1,136,0000.78%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$8,164,0000.75%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders